Neurofit Study Reports Will Comply with the Regulatory Requirements for Electronic Submission
04 September 2007
Neurofit is pleased to announce that starting September 1, 2007 all Neurofit Study Reports will comply with the ICH, FDA and EMEA regulatory requirements for Electronic Submission. Clients will therefore receive both a hard copy and a pdf-version of the final Study Report.
If you need further information, please do not hesitate to contact us.
Neurofit is a preclinical CRO offering in vitro and in vivo drug screening services in the area of pain, psychiatry, neurology and oncology. For more information and details of our screening tests, please visit our website.
